Immunocore Holdings plc (IMCR) Operating cash flow 2021–2025
Immunocore Holdings plc (IMCR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$10.7MFY2025 · since FY2021: -$143.1M → -$10.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.7M | -141.1% |
| FY2024 | $26.1M | +786.4% |
| FY2023 | $2.9M | +106.0% |
| FY2022 | -$49.2M | +65.6% |
| FY2021 | -$143.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IMCR financial trends
IMCR RevenueIMCR Net incomeIMCR Net marginIMCR Gross profitIMCR Gross marginIMCR Operating incomeIMCR Operating marginIMCR Free cash flowIMCR Capital expendituresIMCR Return on equityIMCR Stock buybacksIMCR Dividends paidIMCR Total assetsIMCR Total liabilitiesIMCR Shareholders’ equityIMCR overview →